Early Phase 1 Window of Opportunity Study of Oral DSP-0390 in Grade II and III Gliomas
Latest Information Update: 09 Apr 2025
At a glance
- Drugs DSP 0390 (Primary)
- Indications Glioma
- Focus Pharmacokinetics
Most Recent Events
- 06 Apr 2025 Planned End Date changed from 15 May 2026 to 17 May 2026.
- 06 Apr 2025 Planned primary completion date changed from 15 Apr 2026 to 17 Apr 2026.
- 06 Apr 2025 Status changed from not yet recruiting to recruiting.